Published in J Lipid Res on May 01, 1984
Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br J Clin Pharmacol (1991) 0.89
Liver ischemia for hepatic resection: where is the limit? Surgery (1992) 1.48
Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis. A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis (1976) 1.32
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol (1996) 1.24
Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas (1996) 1.23
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. Circulation (1999) 1.21
Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease. J Clin Invest (1993) 0.99
Elastin-elastase-atherosclerosis revisited. Atherosclerosis (1998) 0.97
Inhibition of LPL expression in human monocyte-derived macrophages is dependent on LDL oxidation state: a key role for lysophosphatidylcholine. Arterioscler Thromb Vasc Biol (1998) 0.89
Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients. Br J Clin Pharmacol (1991) 0.89
Functional analysis of the chimpanzee and human apo(a) promoter sequences: identification of sequence variations responsible for elevated transcriptional activity in chimpanzee. J Biol Chem (2001) 0.89
[Presence of an anti-beta-lipoprotein autoantibody in a myeloma serum]. C R Acad Sci Hebd Seances Acad Sci D (1965) 0.89
Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL. Arterioscler Thromb Vasc Biol (1999) 0.88
Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats. Lipids (1991) 0.88
Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther Drug Monit (1993) 0.88
Interaction between fibroblasts, lipoproteins and three antilipoproteins IgA kappa. Clin Exp Immunol (1980) 0.88
International consensus statement on olive oil and the Mediterranean diet: implications for health in Europe. The Olive Oil and the Mediterranean Diet Panel. Eur J Cancer Prev (1997) 0.87
Lipoprotein kinetics in patients with analbuminemia. Evidence for the role of serum albumin in controlling lipoprotein metabolism. Arterioscler Thromb Vasc Biol (1997) 0.86
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
[Hyperlipidemia caused by auto-antibodies. A cause of atherosclerosis]. Presse Med (1967) 0.83
[Myeloma, hyperlipemia and xanthomatosis]. Nouv Rev Fr Hematol (1965) 0.83
[Myeloma and hyperlipemia. IV. Nature of the specific anti-lipoprotein activity]. Nouv Rev Fr Hematol (1967) 0.83
Macrophage activation syndromes. Nouv Rev Fr Hematol (1992) 0.82
A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Metabolism (1992) 0.82
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. Arterioscler Thromb Vasc Biol (1995) 0.82
Cholesterol synthesis by human fibroblasts in the presence of LDL and anti-LDL IgA. Biomedicine (1979) 0.82
Oleic acid rich diet protects against the oxidative modification of high density lipoprotein. Free Radic Biol Med (1997) 0.82
Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome. Arterioscler Thromb Vasc Biol (1997) 0.82
Effects of dietary fats on the fluidity of human high-density lipoprotein: influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta (1990) 0.81
Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome. Diabetes (1984) 0.81
[Passive hemagglutination with chromium chloride. Its use without macromolecular dilution]. Pathol Biol (Paris) (1969) 0.81
[A further case of hyperlipemia due to auto-antibodies. Its treatment with D-penicillamine]. Bull Mem Soc Med Hop Paris (1967) 0.80
Acute severe herpes simplex hepatitis with virus-associated hemophagocytic syndrome in an immunocompetent adult. J Hepatol (1993) 0.80
Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells. Arterioscler Thromb Vasc Biol (1997) 0.80
The promoter of human tissue factor pathway inhibitor gene: identification of potential regulatory elements. Thromb Res (1999) 0.80
Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients. Atherosclerosis (1995) 0.80
Comparison between extra virgin olive oil and oleic acid rich sunflower oil: effects on postprandial lipemia and LDL susceptibility to oxidation. Ann Nutr Metab (1998) 0.79
Prevalence of dyslipidemia in liver transplant recipients. Transplantation (1992) 0.79
Effects of different dietary intake of essential fatty acids on C20:3 omega 6 and C20:4 omega 6 serum levels in human adults. Lipids (1985) 0.79
[Immunochemical study of the lipoprotein substance Pg (author's transl)]. Pathol Biol (Paris) (1977) 0.79
Effects of probucol on the cholesterol content of skin in type II hyperlipoproteinemias. Artery (1982) 0.78
The hypolipidemic action of probucol. Drug transport and lipoprotein composition in type IIa hyperlipoproteinemia. Atherosclerosis (1985) 0.78
Effects of three dietary fats on plasma lipids and lipoproteins in fasting and post-prandial humans after a short-term diet. Lipids (1980) 0.78
Influence of environmental medium on fatty acid composition of human cells: leukocytes and fibroblasts. Lipids (1987) 0.78
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group. Br J Clin Pharmacol (1994) 0.78
Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis. Ann Biol Clin (Paris) (1992) 0.78
Dietary modifications of low-density lipoprotein fatty acids in humans: their effect on low-density lipoprotein-fibroblast interactions. Clin Physiol Biochem (1986) 0.78
In vitro interaction of LDL, anti-lipoprotein IgA and human fibroblasts. Biomedicine (1978) 0.78
[Presence of a phospholipid in the Pg site that reveals IgA myelomatous antilipoprotein (anti-Pg) ]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.78
Asymptomatic homozygous hypobetalipoproteinemia associated with apolipoprotein B45.2. Hum Mol Genet (1994) 0.78
Dietary fats and lecithin-cholesterol acyltransferase activity in healthy humans. Ann Nutr Metab (1988) 0.77
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients. Clin Chim Acta (1999) 0.77
Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin. Atherosclerosis (1999) 0.77
Olive oil and the Mediterranean diet: implications for health in Europe. Br J Nurs (1997) 0.77
Fluidity changes and chemical composition of lipoproteins in type IIa hyperlipoproteinemia. Biochim Biophys Acta (1990) 0.77
Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop). Atherosclerosis (1997) 0.77
In vitro preparation of elastin--triglyceride complexes. Fatty acid uptake and modification of the susceptibility to elastase action. Atherosclerosis (1980) 0.76
[Is ischemia of the liver, lasting longer than an hour, a severity factor in hepatectomies? Apropos of 19 cases]. Chirurgie (1991) 0.76
Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia. Ann Nutr Metab (1991) 0.76
Dietary monounsaturated fatty acids enhance cholesterol efflux from human fibroblasts. Relation to fluidity, phospholipid fatty acid composition, overall composition, and size of HDL3. Arterioscler Thromb (1993) 0.76
Influence of diet on the plasma levels and distribution of ApoA-I-containing lipoprotein particles. Prog Lipid Res (1991) 0.76
Increased cholesteryl ester transfer activity in plasma from analbuminemic patients. Arterioscler Thromb Vasc Biol (1996) 0.76
[Myeloma, hyperlipidemia and xanthomatosis. 3. A syndrome due to the presence of an anti-beta-lipoprotein autoantibody]. Nouv Rev Fr Hematol (1966) 0.75
Influence of the fatty acid composition of high-density lipoprotein phospholipids on the cholesterol efflux from cultured fibroblasts. Biochim Biophys Acta (1986) 0.75
Comparative study of several hypolipidemic agents related to clofibrate. Atherosclerosis (1974) 0.75
[Treatment of hypercholesteremia with cholestyramine]. Therapeutique (1972) 0.75
[Leg aneurysm complicating bacterial endocarditis. 2 cases]. Presse Med (1983) 0.75
[Atherosclerosis: fundamental mechanisms]. Pathol Biol (Paris) (1983) 0.75
Role of elastic tissue in cholesterol deposition in the arterial wall. Nutr Metab (1973) 0.75
[Physiology of intestinal digestion]. Gaz Med Fr (1966) 0.75
In vivo incorporation of dietary ( 14 C)cholesterol in rat serum lipoproteins and transfers in connective tissue. Clin Chim Acta (1971) 0.75
[Pulmonary emboli caused by hormonal treatment. (Apropos of 2 cases)]. Coeur Med Interne (1973) 0.75
[The hyperlipidemia of atherosclerosis patients]. Rev Prat (1965) 0.75
[Myeloma, hyperlipidemia and xanthomatosis. II. Complementary research on the association between paraprotein and fast lipoproteins]. Nouv Rev Fr Hematol (1966) 0.75
[Fatty diabetes, insulin resistance and anti-insulin antibodies]. Nouv Presse Med (1973) 0.75
[The composition of dietary lipids and the blood coagulation time in the rat]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.75
Effects of antivitamin K on hypolipemic agents in rat. Haemostasis (1974) 0.75
[Physiology of gastric digestion]. Gaz Med Fr (1966) 0.75
[Regression of xanthomas and hypolipidemic drugs]. Atherosclerosis (1974) 0.75
[Pathogeny of atherosclerosis]. Ann Biol Clin (Paris) (1972) 0.75
[Pleomorphic carcinoma of the pancreas with bone metaplasia]. Arch Anat Cytol Pathol (1976) 0.75
[Clinical vascular action of various cigarettes with different concentrations of nicotine]. Pathol Biol (Paris) (1974) 0.75
[Fever and an immunoallergic reaction to cyclofenil]. Rev Med Interne (1986) 0.75
[Atherosclerosis: basic mechanisms]. Sem Hop (1983) 0.75
Effects of factors influencing the activity of the reticuloendothelial system on the half-life of labelled beta-lipoproteins. Preliminary report. J Med (1974) 0.75
[Cholesterol and connective tissue of the arterial wall]. Pathol Biol (Paris) (1974) 0.75
[Prevention with N-acetyl-hydroxyproline on the toxic cellular effects of nicotine]. C R Seances Soc Biol Fil (1971) 0.75
Effect of factors influencing the reticuloendothelial system on the turnover of the rat serum cholesterol. Nutr Metab (1971) 0.75